Insiders Bio-Path Holdings, Inc.

Equities

BPTH

US09057N4097

Market Closed - Nasdaq Other stock markets 21:00:00 09/05/2024 BST			5-day change	1st Jan Change
2.81 ^USD	+1.81%		+5.64%	-69.65%

04-19	Bio-Path Closes $1.2 Million Share Offering	MT
04-18	Bio-Path Holdings, Inc. Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1B Clinical Trial of Bp1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Path Holdings, Inc. Appoints Aline Sherwood to its Board of Directors	06/04/22	CI
Bio-Path Holdings, Inc. Announces Resignation of Martina Molsbergen as Member of the Board and All Committees of the Board	18/02/22	CI
Bio-Path Holdings, Inc. Announces Board Changes	15/10/19	CI
Bio-Path Holdings, Inc. Appoints Paul D. Aubert as Director	21/12/18	CI
Bio-Path Holdings, Inc. Appoints Dr. Jason B. Fleming to its Scientific Advisory Board	16/08/18	CI
Bio-Path Holdings, Inc. Appoints Anas Younes to Scientific Advisory Board	10/05/18	CI
Bio-Path Holdings, Inc. Appoints Paul Aubert to Its Board of Directors	05/02/18	CI
Bio-Path Holdings, Inc. Announces Resignation of Ulrich W. Mueller as Chief Operating Officer	06/09/17	CI
Bio-Path Holdings, Inc. Announces Resignation of Directors	16/08/17	CI
Bio-Path Holdings, Inc. Appoints Mark Colonnese to its Board of Directors	17/07/17	CI
Bio-Path Holdings Announces the Appointment of William Hahne as Vice President of Clinical Development	17/04/17	CI
Bio-Path Holdings Appoints Dr. Craig Hooper to Scientific Advisory Board	21/02/17	CI
Bio-Path Holdings, Inc. Announces Board Appointments	31/08/15	CI
Bio-Path Holdings, Inc. Appoints Tara Sadeghi as Director of Clinical Operations	30/04/15	CI
Bio-Path Holdings, Inc. Announces Board Changes	03/11/14	CI
Bio-Path Holdings, Inc. Announces Resignation of Douglas P. Morris as Vice President of Corporate Development and Secretary, Effective June 30, 2014	03/07/14	CI
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller as Chief Operating Officer	26/03/14	CI
Bio-Path Holdings, Inc. Announces Management Appointments	13/02/14	CI
Bio-Path Holdings, Inc. Elects Michael J. Garrison as Director	17/12/12	CI
Bio-Path Holdings, Inc. Appoints Michael J. Garrison as Director	03/10/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Bio-Path Holdings, Inc.

Equities

BPTH

US09057N4097

Insiders

Filters